Key details
Sponsor
University of Virginia
Collaborators
American Cancer Society, Inc., Integrated Translational Health Research Institute of Virginia (iTHRIV)
Enrollment target
~30 participants
Primary completion
October 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 90 Years
Last updated December 2024